UNIVERSITY RESPONSE TO COVID-19 :
The Biology Program Presents: Dr. Alina Baum
“Drug Development at Warp Speed: The History of a COVID-19 Antibody Program” by Dr. Alina Baum
Alina Baum is a Senior Staff Scientist at Regeneron Pharmaceuticals, where she is leading the COVID-19 spike antibody program currently in clinical trials. She received her PhD in molecular virology from the lab of Adolfo Garcia-Sastre at Mount Sinai School of Medicine and performed postdoctoral studies with Charlie Rice at Rockefeller University. Her virology research group has developed novel therapies for many viral infections, including emerging pathogens such as Ebola and SARS-CoV-2, as well as developing oncolytic viruses and therapeutic vaccines for cancer immunotherapy.
Zoom ID: 96434284778